Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $99.3400 (2.4%) ($95.6800 - $99.3400) on Mon. Aug. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.38% (three month average) | RSI | 60 | Latest Price | $99.3400(2.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 2% a day on average for past five trading days. | Weekly Trend | LGND advances 1.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(50%) IWN(50%) IWO(50%) IWC(48%) IBB(47%) | Factors Impacting LGND price | LGND will decline at least -1.69% in a week (0% probabilities). UUP(-17%) VXX(-16%) VIXM(-8%) TBT(-8%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.69% (StdDev 3.38%) | Hourly BBV | 2.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $96.07(3.4%) | 10 Day Moving Average | $94.57(5.04%) | 20 Day Moving Average | $94.03(5.65%) | To recent high | 0% | To recent low | 33.5% | Market Cap | $1.596b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |